Introduction

Integrated DNA Technologies (IDT), a leader in genomic solutions, has unveiled plans for a new innovation hub located in Redwood City. This facility aims to bolster collaboration within the burgeoning Bay Area biotechnology cluster.

The Purpose of the Innovation Nexus

The Innovation Nexus is set to serve as a collaborative center, allowing IDT to work closely with regional customers and partner with leading biotechnology firms. The facility will enhance research and development (R&D) initiatives to drive advancements in the field.

Strategic Focus on Synthesis Technologies

This innovation hub is integral to IDT’s strategic direction, focusing on the adoption of transformative synthesis technologies. These developments range from innovative chemistries to enzymatic practices and non-traditional platforms. The goal is to facilitate growth in precision oncology through advanced next-generation sequencing (NGS) methodologies.

Expanding NGS Portfolio

IDT’s NGS offerings, notably those under the xGen™ brand, include a spectrum of solutions from library preparation and target enrichment to end-to-end assay platforms equipped with secondary analysis and tertiary software capabilities. These advanced solutions aid cancer researchers by providing high-quality sequencing and insightful data interpretation.

Commitment to Customer Engagement

“The installation of IDT’s Innovation Nexus reflects our commitment to engaging closely with customers and strategic partners, and equipping them with novel solutions, tools of unrivalled quality, and trusted expertise,” stated Linda De Jesus, VP/GM Global Head of Commercial at IDT.

She further emphasized that IDT is expanding beyond its traditional offerings of oligo synthesis, positioning itself as a comprehensive resource for high-quality scientific capabilities and insight.

Legacy and Leadership

Originating from Coralville, Iowa, IDT’s headquarters continue to drive innovation alongside the new Redwood City facility. The hub will also include a new leadership role dedicated to transforming technical capabilities to meet customer demands, focusing on R&D initiatives.

Conclusion

The Innovation Nexus represents a significant leap forward in IDT’s commitment to fostering scientific advancements globally. By enhancing collaboration and innovation, IDT aims to empower researchers and contribute to meaningful breakthroughs in genomic sciences.

About Integrated DNA Technologies

Integrated DNA Technologies has evolved from a simple oligonucleotide manufacturer into a major player in genomics, dedicated to catalyzing scientific and public health advancements. As part of Danaher Corporation, IDT is well-positioned to combine capabilities to drive impactful scientific innovations aimed at improving health worldwide.